Dario expands pharma collaborations with global pharma leader to enhance user engagement

The new platform services subscription contract with a top six u.s. pharma client marks a pivotal shift in dario's pharma channel, transitioning the business model from milestone-based to recurring service subscription fees by expanding engagement with payors and pharmacy benefit managers (pbms) new york , nov. 4, 2024 /prnewswire/ -- dariohealth corp. (nasdaq: drio) ("dario" or the "company"), a leader in the global digital health market, announced today a new collaboration with a pharma company that will utilize dario connect (formerly twill care) among their patient populations to further their direct-to-consumer efforts using dario's refined engagement and navigation technologies. in an effort to strengthen and expand connections across patient populations that are candidates for a new drug to treat psoriasis, a top pharmaceutical company chose dario to pilot a cutting-edge initiative aimed to help onboard patients that will engage with the drug via the platform.
DRIO Ratings Summary
DRIO Quant Ranking